|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.85 SAR | -1.08% |
|
-0.27% | -3.32% |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
| 11-03 | HSBC Trims Nahdi Medical PT, Affirms Buy Rating | MT |
Executive Committee: Nahdi Medical Company
| Manager | Positions heldSince | ||
|---|---|---|---|
Yasser Joharji 55 year |
| ||
Hossam Khattab 44 year |
| ||
Mohammed Al-Khubani 52 year |
| ||
Samer Bokharee 47 year |
| ||
Khalid Tadlaoui 59 year |
|
Composition of the Board of Directors: Nahdi Medical Company
| Director | CommitteesSince | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Saleh bin Mahfouz 75 year |
| ||||||||||
Junaid Bajwa 47 year |
| ||||||||||
Abdulatif Al-Seif 47 year |
| ||||||||||
Abdelelah bin Mahfouz 73 year |
| ||||||||||
Romain Voog 54 year |
| ||||||||||
Yasser Joharji 55 year |
| ||||||||||
Abdullah Amer Al Nahdi 64 year |
|
Former Officers and Directors: Nahdi Medical Company
| Insider | Positions held SinceUntil | |||
|---|---|---|---|---|
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
|
Age distribution of managers
Parity Men Women
| Male | 11 |
|---|---|
| Female | 0 |
Of which Executive Committee
| Male | 5 |
|---|---|
| Female | 0 |
Of which Directors
| Male | 7 |
|---|---|
| Female | 0 |
Revisions
ESG MSCI
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















